References
- Huang R, Zhu L, Xue L, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14(5):e0008280. doi:https://doi.org/10.1371/journal.pntd.0008280.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. Published online March 31, 2020. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:https://doi.org/10.1016/S0140-6736(20)31014-X.
- Quillen DA, Davis JB, Gottlieb JL, et al. The white dot syndromes. Am J Ophthalmol. 2004;137(3):538–550. doi:https://doi.org/10.1016/j.ajo.2004.01.053.
- Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol. 1984;102(5):671–674. doi:https://doi.org/10.1001/archopht.1984.01040030527008.
- François J, Collery AS, Hayek G, et al. Coronavirus disease 2019–associated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2021;139:247–249. Published online December 17, 2020. doi:https://doi.org/10.1001/jamaophthalmol.2020.5695.
- Zhou S, Jones-Lopez EC, Soneji DJ, Azevedo CJ, Patel VR. Myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and myelitis in COVID-19. J Neuroophthalmol. 2020;40(3):398–402. doi:https://doi.org/10.1097/WNO.0000000000001049.
- Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270. doi:https://doi.org/10.1056/NEJMc2008597.
- Lee M-H, Perl DP, Nair G, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med. Published online December 30, 2020. doi:https://doi.org/10.1056/NEJMc2033369.
- Invernizzi A, Pellegrini M, Messenio D, et al. Impending central retinal vein occlusion in a patient with coronavirus disease 2019 (COVID-19). null. 2020;28(8):1290–1292. doi:https://doi.org/10.1080/09273948.2020.1807023.
- Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye. 2020;34(12):2352–2353. doi:https://doi.org/10.1038/s41433-020-1069-8.
- Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279. doi:https://doi.org/10.1136/svn-2020-000431.
- Clark A, Jit M, Warren-Gash C. et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Global Health. 2020;8:e1003–e1017. doi:https://doi.org/10.1016/S2214-109X(20)30264-3.